(1 - 9 von 10
)
INTERIM REPORT JANUARY-JUNE 2008
www.globenewswire.com
· ... please contact: Per Olof Wallström, President, tel. + Per Otteskog, Senior Vice President Investor Relations, tel.
Karo Bio and Zydus Cadila Sign Research Agreement for Development of...
www.technologynetworks.com
Both companies initiate a three year research collaboration with the purpose to discover and develop selective glucocorticoid receptor.
karo bio and wyeth collaboration − targets inflammation
www.globenewswire.com
continued collaboration" says Per Olof Wallström, President of Karo Bio. For further information, please contact: Per Olof Wallström, President &Chief ... › Attachment
Camurus AB: The Nomination Committees proposal to the ...
www.moneycontroller.co.uk
— Max Mitteregger, appointed by Gladiator, and Per Olof Wallström, chairman of the Board. Per Sandberg was elected chairman of the Nomination ... › ...
Karo Bio and Wyeth Extend Research Collaboration
www.technologynetworks.com
— ... our joint collaboration and we see great opportunities for compounds that target LXR”, says Per-Olof Wallström, President of Karo Bio. › ...
Wyeth Continues Karo R&D Activities - Contract Pharma
www.contractpharma.com
— However, the Collaboration, Research and License Agreement between the companies shall remain in effect,” said Per Olof Wallström, ... › ...
Wyeth to Take Over Research Projects Initiated in ...
www.genengnews.com
— Karo will therefore not receive any further research funding from Wyeth, according to Per Olof Wallström, president and CEO of Karo Bio. › news
sortiert nach Relevanz / Datum